Status:
COMPLETED
Examination of ACT Implementation in a Vivax / Falciparum Co-endemic Area
Lead Sponsor:
London School of Hygiene and Tropical Medicine
Collaborating Sponsors:
Health Protection and Research Organisation
HealthNet TPO
Conditions:
Malaria
Fever
Eligibility:
All Genders
Phase:
PHASE4
Brief Summary
In areas of which are co-endemic for vivax and falciparum malaria, treatments for the two diseases often differ and this may lead to mistreatment. This places an emphasis on diagnosis at the health se...
Detailed Description
The study will randomly assign diagnostic methods, either with clinical diagnosis, field microscopy or rapid diagnostic tests. The study will take place in 22 clinics in Eastern and Northern Afghanist...
Eligibility Criteria
Inclusion
- Any patient where the clinician\* considers malaria in the diagnosis - either prescribing an antimalarial or would request a malaria test if available or referring for diagnosis of malaria elsewhere.
- Patient, or parent/guardian, gives informed consent to the study.
Exclusion
- Patients with a result from another facility
- Patients referred on for diagnosis in the private sector
- Patients the clinician decides to treat presumptively without requesting a test (defined as treating prior to randomisation)
- Where the clinician requests microscopy specifically due to clinical need prior to randomisation will not be randomised in the trial, but will be noted as part of the study and a reference slide and clinical information will be taken following consent.
Key Trial Info
Start Date :
May 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 1 2010
Estimated Enrollment :
4200 Patients enrolled
Trial Details
Trial ID
NCT00935688
Start Date
May 1 2009
End Date
October 1 2010
Last Update
February 7 2014
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Merlin
Kunduz, Kunduz, Afghanistan
2
HealthNet TPO
Jalalabad, Nangarhar, Afghanistan